Myocardial infarction associated with erenumab: A case report-Reference-Cited by-同舟云学术

Myocardial infarction associated with erenumab: A case report

Published:2022-06-08 Issue:7 Volume:42 Page:585-589
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Perino Justine¹²^ORCID,Corand Virginie³,Laurent Elise¹,Théophile Hélène¹,Miremont‐Salamé Ghada¹,Pariente Antoine¹²,Colas Jean‐Laurent⁴,Couffinhal Thierry⁵,Salvo Francesco¹²^ORCID

Affiliation:

1. Pharmacovigilance Center of Bordeaux, Department of Medical Pharmacology University Hospital of Bordeaux Bordeaux France

2. Univ. Bordeaux, INSERM, BPH, U1219 Bordeaux France

3. Pain Center of Bordeaux, Department of Clinical Neurosciences University Hospital of Bordeaux Bordeaux France

4. Department of Cardiology Polyclinique Bordeaux Nord Aquitaine Bordeaux France

5. Univ. Bordeaux, INSERM, Biology of Cardiovascular Diseases, U1034, CHU de Bordeaux Bordeaux France

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2706

Reference17 articles.

1. Blockade of CGRP Receptors in the Intracranial Vasculature: A New Target in the Treatment of Headache

2. An Immunocytochemical Investigation of Human Trigeminal Nucleus Caudalis: Cgrp, Substance P and 5-Ht1D-Receptor Immunoreactivities Are Expressed by Trigeminal Sensory Fibres

3. Calcitonin Gene-Related Peptide: Physiology and Pathophysiology

4. The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects

5. CGRP inhibitors for migraine prophylaxis: a safety review

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of alpha CGRP exacerbates the development of atherosclerosis in ApoE-knockout mice;Scientific Reports;2024-08-08

2. Quantitative proteomics reveals CLR interactome in primary human cells;Journal of Biological Chemistry;2024-06

3. Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine;Frontiers in Neurology;2024-04-29

5. Potential benefits and possible risks of CGRP-targeted multitherapy in migraine;Expert Opinion on Drug Metabolism & Toxicology;2024-02